Localization Barriers To Trade In Medicines And Health Care Products: The Tricky Business Of Balancing Competing Interests

AP
Arnold & Porter

Contributor

Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
He also highlights the increasingly challenging political and economic environment faced by industries.
United Kingdom International Law

In this article, Dr. Lincoln Tsang examines the increasing importance of trade policy and agreement in cross-border trade of pharmaceutical and healthcare products and access to essential pharmaceutical and biological medicines to maintain a sustainable healthcare ecosystem. He also highlights the increasingly challenging political and economic environment faced by industries. The impact of WTO rules on the application of localization policies as an economic tool and the impact of trade rules post-Brexit are also discussed.

» Read the full article (requires Pink Sheet login).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More